Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Physicians diagnose around 40% of those over the age of 90 with Alzheimer’s disease, according to Robert Vassar, director of Northwestern’s Mesulam Center for Cognitive Neurology and Alzheimer’s ...